<DOC>
	<DOC>NCT02183259</DOC>
	<brief_summary>To investigate the bioavailability of ESR 1150 CL by the time course determination of plasma concentration (pharmacokinetics) of no-transformed ESR 1150 after single administration to healthy adult male volunteers. Secondary objective is to investigate the safety of ESR 1150 CL.</brief_summary>
	<brief_title>Bioavailability, Pharmacokinetics and Safety of ESR 1150 CL in Healthy Adult Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>healthy male subjects age: &gt;= 20 and &lt;= 35 years weight: &gt;= 50 to &lt;= 80 kg and within +/ 20 % of standard weight blood pressure: systolic 100 138 mmHg and diastolic of less than 84 mmHg pulse rate: 45 to 80 beat/min volunteer whose participation in the trial is judged valid by the investigator based on the results of preliminary checkup and preadministration checkup history of diseases including cardiac, pulmonary, hepatic, renal or gastrointestinal disease history of drug allergy history of drug dependency, alcohol dependency, etc. use of other trial drug within 6 months before study drug administration use of any drugs within 7 days before study drug administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>